Posters
« Back
Medical Student: Is Naloxone Use in the Southeast Rising?
EP30805
Poster Title: Medical Student: Is Naloxone Use in the Southeast Rising?
Submitted on 15 Oct 2019
Author(s): Katherine Westbrook OMS III, Kiara Touros OMS III., Dr. Robert Parker, Morgan Thorn, Divyesha Patel, Dr. Emmanuel Segui
Affiliations: Alabama College of Osteopathic Medicine
Poster Views: 204
View poster »


Poster Information
Abstract: Fatalities caused by drug-overdose have increased greatly in recent years across the US and is now the leading cause of injury-related death in the United States. Drug related deaths with cointoxicants are being seen far too often and the increase in prevalence of opioid overdoses with possible concomitant medication use is a public health concern that needs to be addressed. Naloxone (Narcan ®) is an opioid antagonist approved in November 2015 by the FDA to help combat the effects of opioid overdose. Awareness of naloxone’s availability over the counter and education on opioid related overdoses for communities in the United States has been shown to improve opioid overdose deaths. In this study, we document naloxone administration in the Southeast Health Emergency Department to help identify high risk sub-populations in this region that present with signs of potential opioid overdose and the connection between overdoses for opioids or a cointoxicant.Summary: We would like to determine and document the prevalence of naloxone administration in Southeast Alabama at Southeast Health, a level II trauma center emergency department (ED), and let this data guide future opioid prescribing and education efforts. Our research will also help identify high risk sub-populations of southeast Alabama residents that present to emergency departments with signs of potential opioid overdose.
References: 1. Prabhu, MD, A., Abaid, MD, B., Khaleel, MD, M., Naik, MD, S., Lippman, MD, M., Lippman, MD, S. (2018, May). The Naloxone Option. https://www.mdedge.com/jfponline/article/164313/addiction-medicine/naloxone-option
2. Dowell, D, Haegerich TM, C. (2016). CDC Guideline for Prescribing Opioids for Chronic Pain. https://www.fda.gov/downloads/Drugs/NewsEvents/UCM454748.pdf
3. Lloyd, MD, J. The Clinical Use of Naloxone. https://www.fda.gov/downloads/Drugs/NewsEvents/UCM454748.pdf
4. RX List. (2017, January 13). NARCAN. https://www.rxlist.com/narcan-drug.htm#description
5. Verdier, M, et al. (2018, May 22). Naloxone Prescriptions from the Emergency Department: An Initiative in Evolution. https://www.ajemjournal.com/article/S0735-6757(18)30422-4/fulltext
6. Centers for Disease Control and Prevention. (2017, July 31). Opioid Overdose: US State Prescribing Rates 2016. https://www.cdc.gov/drugoverdose/maps/rxstate2016.html
7. Ivey, Kay. (2017, December 31).
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Antimicrobial Resistance and Global Threat
Sambasivarao Yaragalla, Preksha Shah and Kaligota SahithiBhavani

COVID 19 and Dentistry- Look at the brighter reflection
Sonal Kale

The Ebola Virus: Community Awareness
SAMBASIVARAO YARAGALLA, Navami Guru, Dagbue Sophia, Hernandez Aleyda San, Kamal sepla, Alrashid Zaid Arkan, Daniel Cheong, Abhinaya Murali, Chelsea Dilsuk, Khushal Alete, Savin Peter, Badrinarayana Ajay Maharaj

ANTIMICROBIAL ACTIVITY OF NEWER DISINFECTANT ON MULTIDRUG RESISTANCE ORGANISMS IN ST.LUCIA
DR. SAMBASIVARAO YARAGALLA, DHRUV PATEL,MEET PATEL, OKUNLOLA OLUWASEMILORE I , CHUKWUEBUNI ONYEBUCHI HANNAH, IJEOMA NWABUOKEI

HRCT PATTERN IN USUAL INTERSTITIAL PNEUMONIA
Dr Azim Ilyas